Abstract
Cognitive impairment is a common complication of multiple sclerosis, even in early stage disease, with significant impacts on life quality and social interaction. However, its detection is highly test-dependent. To validate a recently described screening tool, the ARCS, for detecting cognitive impairment in a multiple sclerosis population. The ARCS administers tests of executive function, memory, visual spatial construction and language via an audio device to unsupervised patients who write their responses for later scoring. Some 127 patients with a wide variety of disease course and severity were assessed by ARCS, of whom 87 also completed the Paced Auditory Serial Addition Test (PASAT) and 45 underwent formal ('gold standard') neuropsychological testing. Compared with PASAT, we found that the ARCS showed better sensitivity (86% versus 68%) at equivalent specificity (71%) for detection of impairment in any cognitive domain, and superiority in the detection of memory and executive impairments. Acceptance and completion rates for the ARCS were as good or better than for the PASAT. ARCS is sensitive, well-tolerated, easy to administer and facilitates comprehensive cognitive assessment in less than 5 min of clinician time. It has ...Continue Reading
References
Apr 1, 1977·Perceptual and Motor Skills·D M Gronwall
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
May 1, 1991·Neurology·S M RaoF Unverzagt
Jan 1, 1990·Archives of Neurology·J M PeyserE Kaplan
Sep 1, 1987·Archives of Gerontology and Geriatrics·M A Verity, A F Wechsler
Jan 1, 1973·Acta Oto-laryngologica·A R FreglyA Graybiel
Mar 1, 1994·Neuropsychology Review·A Benton
Jan 1, 1994·Archives of Neurology·G J ReyK Nedd
Nov 4, 2000·Neurology·L B Krupp, L E Elkins
Jul 19, 2001·Journal of the International Neuropsychological Society : JINS·J V BaldoE Kaplan
Sep 21, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K T DelisJ H Wolfe
Oct 27, 2001·Archives of Neurology·M P AmatoS Sorbi
Feb 18, 2003·Journal of the American Geriatrics Society·Peter W SchofieldGraeme C Davies
Mar 1, 2005·Multiple Sclerosis : Clinical and Laboratory Research·H CooD G Brunet
Mar 30, 2005·Multiple Sclerosis : Clinical and Laboratory Research·T OlivaresJ Barroso
Jul 12, 2005·The British Journal of Clinical Psychology·Julie D Henry, John R Crawford
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Sep 20, 2006·Journal of the International Neuropsychological Society : JINS·Ralph H B BenedictBianca Weinstock-Guttman
Feb 14, 2007·Multiple Sclerosis : Clinical and Laboratory Research·L FeuilletJ Pelletier
Oct 9, 2007·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Carolina GarciaConcetta Forchetti
Nov 13, 2007·Journal of the Neurological Sciences·Constantin PotagasDemetris Vassilopoulos
Jul 11, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Sep 27, 2008·La Radiologia medica·R ChiavaroliP Grima
Sep 15, 2009·Lancet Neurology·Ludwig KapposUNKNOWN BENEFIT Study Group
Dec 8, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·Peter W SchofieldMark McEvoy
Dec 24, 2009·Multiple Sclerosis : Clinical and Laboratory Research·A S DrakeR H B Benedict
Citations
May 4, 2012·BMC Neurology·Peter W SchofieldSonya R Murray
Aug 1, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Isla M WilliamsLarry A Abel
Jan 9, 2020·The Journal of ECT·Alan Michael WeissPeter William Schofield
Apr 3, 2019·Nutrients·Lesley MacDonald-WicksKarly Zacharia
Oct 1, 2010·Acta Neuropsychiatrica·Carmel M LoughlandVaughan J Carr
Dec 19, 2018·Multiple Sclerosis Journal - Experimental, Translational and Clinical·L De MeijerA Van der Walt
Feb 23, 2021·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Jameen ArmSaadallah Ramadan
Mar 23, 2020·Multiple Sclerosis and Related Disorders·Vicki E MaltbyJeannette Lechner-Scott
May 3, 2011·Current Opinion in Neurology